Strata Medical (SRTA) Enterprise Value to EBITDA Ratio
Strata Critical Medical Inc (SRTA) maintains a strong position in the high-precision medtech equipment segment, while its organ transport operations remain insulated from economic cycles and GDP fluctuations. This chart reflects current share prices with an EV/EBITDA multiple of 49.23. Management is currently restructuring the operating model to meet the needs of private air ambulance services, while the market assesses the efficiency of fleet utilization within a venture capital approach.
Comprehensive metric breakdowns and analytics for blade.com (SRTA)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Strata Critical Medical Inc|SRTA - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Strata Critical Medical|SRTA - Company Total Debt|Debts to Book Capitalization Strata Medical|SRTA - Long-Term Debt|Company Short-Term Debts Strata Critical Medical|Quick Ratio blade.com
- financial results and valuation multiples details:
SRTA - Net Financial Result|Projected Future Earnings Strata Critical Medical Inc|SRTA - Price to Earnings Ratio|Forward P/E Multiple Strata Critical Medical Inc|SRTA - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Strata Medical|SRTA - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Strata Critical Medical|SRTA - Earnings per share for the trailing year|Quarterly EPS earnings growth blade.com|SRTA - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Strata Critical Medical Inc
Analysis of all company metrics:Strata Critical Medical Corp SRTA
For Strata Critical Medical (SRTA), which is developing urban air mobility infrastructure, this multiple serves as a key measure of debt sustainability. Analyzing the Enterprise Value to EBITDA chart on GURU.Markets, an investor can see the ratio of the business's total market value to its operating profit before depreciation and taxes. This allows for an assessment of the real value of assets relative to the ability to generate cash flow. An increase in this metric may signal overvaluation or a critical increase in leverage.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation IRMD|EMBC (Embecta) - EV/EBITDA Multiple|Tandem Diabetes Care Inc (TNDM) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AXGN|Enterprise Value to EBITDA Ratio SI-BONE Medical SIBN|EV/EBITDA Multiple OFIX (Orthofix Medical Inc.)|EV/EBITDA Multiple bioventus.com BVS|KIDS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TMCI: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CARL (Carlsmed Corp) - Enterprise Value to EBITDA Ratio|RxSight Ophthalmic - Business Value to Operating Income Before Depreciation|CLPT (ClearPoint Neuro Inc.) - EV/EBITDA Multiple|Company Value to EBITDA stereotaxis.com STXS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Neuronetics (STIM)|Sight Sciences Inc. (SGHT) - Enterprise Value to EBITDA Multiple|Orchestra BioMed - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Anika Therapeutics Inc. ANIK|InspireMD, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Jin Medical International ZJYL|vivani.com (VANI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XTNT (Xtant Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NeuroOne Corp|Enterprise Value to EBITDA Ratio Modular Med (MODD)|EV/EBITDA Multiple MYO|COCH - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vivos Therapeutics, Inc. VVOS|NVNO: Enterprise Value to Operating Income Before Depreciation|SINT: Enterprise Value to EBITDA Ratio|Tenon Medical Inc - Enterprise Value to Operating Income Before Depreciation Ratio|ReWalk Robotics Ltd. (LFWD) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|AMIX - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio IVF|BBLG (Bone Biologics Corp.) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Axonics Modulation Technologies (AXNX)|BIOL (Biolase Inc.) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple DYNT (Dynatronics)|EV/EBITDA Multiple Paragon 28 Inc. FNA|INVO: Enterprise Value to EBITDA Ratio
